Allworth Financial LP Seagen Inc. Transaction History

Allworth Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$191.51 - $216.16 $14,363 - $16,212	75 Added 138.89%	129 $27,000
Q1 2023 Apr 18, 2023	BUY	$127.59 - $203.08 $1,403 - $2,233	11 Added 25.58%	54 $10,000
Q4 2022 Jan 13, 2023	BUY	$117.37 - $139.17 $1,760 - $2,087	15 Added 53.57%	43 $0
Q3 2022 Oct 18, 2022	SELL	$135.27 - $180.11 $16,502 - $21,973	-122 Reduced 81.33%	28 $4,000
Q2 2022 Jul 13, 2022	BUY	$108.81 - $179.33 $14,906 - $24,568	137 Added 1053.85%	150 $27,000
Q1 2022 Apr 22, 2022	BUY	$119.61 - $157.85 $1,554 - $2,052	13 New	13 $2,000
Q1 2021 Apr 29, 2021	SELL	$137.51 - $190.8 $1,650 - $2,289	-12 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$164.63 - $211.93 $1,975 - $2,543	12 New	12 $2,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.